Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications/Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen/Erms Phone: +49 (0)7123 724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free ...
Further inquiry note: For further information, please contact: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional ...
Further inquiry note: Agennix AG Investor Relations & Corporate Communications Phone: +49 (0)89 8565 2693 ir@agennix.com In the U.S.: Laurie Doyle Director, Investor Relations & Corporate Communications Phone: +1 609 524 5884 laurie.doyle@agennix.com Additional media contacts for Europe: MC Services AG Phone: +49 (0) 89 210 228 0 Raimund Gabriel raimund.gabriel@mc-services.eu Hilda Juhasz hilda.juhasz@mc-services.eu Additional investor contact for Europe: Trout ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Fon: +49 (0)7123-724-631; +49 (0)170-9246264; Fax: +49 (0)7123-724-641 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade ...
Ludwigshafen (ots) - Just like animals and human beings, plants can get sick. In many cases, the cause is a fungus. Not a mushroom like you see poking up out of the ground in the woods, but a network of branching, filamentary cells that botanists call 'hyphae'. In entertaining episodes our Chemical Reporter answers questions of our Podcast listeners ...
Further inquiry note: LPKF Laser & Electronics AG Bettina Schäfer, Investor Relations Tel: (05131) 7095-382 Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technology All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade ...
init innovation in traffic systems AG
- Innovation Award for new online diversion module in operations control system - Prompt reaction to current traffic disruptions, real-time information for passengers - On-road test at Bavarian transportation provider DB Stadtverkehr Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 ...
Ingelheim, Germany (ots/PRNewswire) - Boehringer Ingelheim announced today the initiation of a new phase III clinical trial to evaluate one of its two late-stage oncology pipeline compounds for the treatment of patients with advanced ovarian cancer. The clinical study, called LUME-Ovar-1 trial, investigates the compound BIBF 1120, a novel oral anti-angiogenic agent[1], ...
Further inquiry note: For further information, please contact: ElringKlinger AG Investor Relations / Corporate Communications Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / ...
- SCHOTT Solar acquires WACKER's shares in joint venture - WACKER is expecting from the transaction a non-recurring negative effect on pre-tax profit of about 50 million, financial debt to increase by some 65 million - CEO Staudigl: Focus on polysilicon production provides an excellent base for long-term competitiveness and profitability Further inquiry note: Christof Bachmair Media Relations & Information Tel.: ...
Further inquiry note: Investor Relations Tel.: +49 (0)89 6279 1633 E-Mail: investor.relations@wacker.com Branche: Chemicals ISIN: DE000WCH8881 WKN: WCH888 Index: Midcap Market Index, MDAX, CDAX, Classic All Share, HDAX, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard ...
Ludwigshafen (ots) - In this podcast you will learn how chemical innovations from BASF help to make solar energy more economical on its way being a sustainable contribution to the worldwide energy supply. As a part of the future energy mix with other energy sources solar energy can make a sustainable contribution towards a low carbon society. In ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, ...
Ingelheim, Germany (ots/PRNewswire) - - Data From Phase II Studies Investigating BIBW 2992 (Tovok(TM)) and BIBF 1120 (Vargatef(TM)) in NSCLC Patients Presented at 13th World Conference on Lung Cancer (WCLC) INGELHEIM, Germany, August 3 /PRNewswire/ -- Boehringer Ingelheim announced today at the International ...
Cape Town, South Africa (ots/PRNewswire) - - For Medical Media Outside the US Only Results from the ARTEN* trial presented at the 5th International AIDS Society (IAS) conference in Cape Town, South Africa demonstrated non-inferiority regarding efficacy between Viramune(R) (nevirapine) and ritonavir boosted ...
Ingelheim, Germany (ots/PRNewswire) - - For Medical Media Outside the US only Boehringer Ingelheim announced today that the European Commission has approved an update of the Summary of Product Characteristics (SmPC) for VIRAMUNE(R) (nevirapine) in the treatment of patients with HIV. The decision followed a positive recommendation by the Committee for Medical Products ...
Annual General Meeting Further inquiry note: Stephan Haas Investor Relations/PR Telefon: +49(0)7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Frankfurt / regulated dealing/prime standard Berlin / free trade Düsseldorf / free trade München / free ...
Amstetten/Munich (ots) - For ertex solar tradition is not appropriate with imagination, but rather with the traditional slogan of "no limits". This proves the Austrian solar expert once more at the newly designed booth at Intersolar 2009 in Munich. A photovoltaic façade whit the dimension of 5.7 meters in width and 3.0 meters in height, consisting of four elements (each 1.4 x 3.0 m) shows impressively the feasibility of ...
Further inquiry note: For further information, please contact: ElringKlinger AG Corporate Communications / Investor Relations Stephan Haas Max-Eyth-Straße 2 72581 Dettingen Phone: +49 0 7123-724-137 E-mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, ...
Further inquiry note: Stephan Haas Phone: +49 (0) 7123 724 137 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: MDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
init innovation in traffic systems AG
Further inquiry note: Alexandra Weiß Investor Relations Telefon: +49(0)721 6100-102 E-Mail: aweiss@initag.de Branche: Semiconductors & active components ISIN: DE0005759807 WKN: 575980 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / ...
Ludwigshafen (ots) - In simple terms, behind the glass on the front of a plasma screen you'll find a whole lot of tiny cells that are filled with one of the 'noble' gases, generally neon or xenon. Each of these cells represents a single point - a pixel. If a voltage is applied to the gas, then it ...
Ingelheim, Germany, November 17 (ots/PRNewswire) - - Progress Continues Across Expanding Oncology Pipeline With Two Compounds now in Phase III Clinical Development and a Potential First-in-Class Polo-Like Kinase 1 Inhibitor Soon to Enter Phase II - For non-US Healthcare Media Boehringer Ingelheim has marked a new ...
Ludwigshafen (ots) - After the advent of liquid crystal displays, or LCDs, everybody nowadays has at least heard the term 'liquid crystal'. The high-tech screens are everywhere: in computer monitors, cell phones, digital cameras, and calculators. In entertaining episodes our Chemical Reporter ...
LPKF interviewed by Dr. Kalliwoda Research Further inquiry note: Ulrike Thoms-von Meding LPKF Laser & Electronics AG Tel.: +49(0)5131 7095 326 u.thomsvonmeding@lpkf.de Branche: Semiconductors & active components ISIN: DE0006450000 WKN: 645000 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse ...
Ingelheim, Germany (ots/PRNewswire) - - BI 6727, a Highly Potent and Selective Plk1 inhibitor, Represents Latest Advance in Company's Plk1 Programme - For non-US Healthcare Media Boehringer Ingelheim's most promising new cell cycle kinase inhibitor and potentially first-in-class compound, BI 6727, has shown ...
Further inquiry note: Stephan Haas Telefon: +49(0)7123 724 631 E-Mail: stephan.haas@elringklinger.de Branche: Automotive Equipment ISIN: DE0007856023 WKN: 785602 Index: CDAX, Classic All Share, Prime All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse ...
- Expansion of REIS segment with additional retail properties - Capital commitment of 10 million euro from investors - Significant earnings lift expected from 2009 Further inquiry note: InCity Immobilien AG André Peto Phone: +49 (0) 221 95 27 57 55 a.peto@incity.ag Investor Relations Dariusch Manssuri Phone: +49 (0) 221 91 40 970 dariusch.manssuri@ir-on.com Branche: ...
